| Title | Authors / Editors | Date |
unige:158265 |
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
Mongin, Denis; Lauper, Kim; Finckh, Axel; Frisell, Thomas; Courvoisier, Delphine |
2022 |
unige:158272 |
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology |
Lauper, Kim; Kedra, Joanna; de Wit, Maarten; Fautrel, Bruno; ... Courvoisier, Delphine |
2021 |
unige:146396 |
Are we approaching the end of pediatric culture-negative osteoarticular infections? |
Ceroni, Dimitri; Dayer, Romain Olivier Pierre; Steiger, Christina |
2019 |
unige:100059 |
Association between oropharyngeal carriage of Kingella kingae and osteoarticular infection in young children: a case-control study |
Gravel, Jocelyn; Ceroni, Dimitri; Lacroix, Laurence Elisabeth; Renaud, Christian; ... Manzano, Sergio |
2017 |
unige:107098 |
Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting |
Favier, Guillaume; Gladman, Dafna D; Merola, Joseph F; Armstrong, April W; ... Helliwell, Philip S |
2017 |
unige:26029 |
Benefits of a programme taking advantage of patient-instructors to teach and assess musculoskeletal skills in medical students |
Bideau Sar, Martine; Guerne, Pierre-André; Bianchi, M-P; Huber, Philippe |
2006 |
unige:99160 |
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis |
Gottenberg, J E; Courvoisier, D S; Hernandez, M V; Iannone, F; ... Finckh, Axel |
2016 |
unige:157913 |
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities |
Kvien, Tore K; Balsa, Alejandro; Betteridge, Neil; Buch, Maya H; ... Dougados, Maxime |
2020 |
unige:157869 |
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial |
Burmester, Gerd R; Buttgereit, Frank; Bernasconi, Corrado; Álvaro-Gracia, Jose M; ... John, Markus R |
2020 |
unige:99458 |
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F |
2016 |
unige:125829 |
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study |
Deodhar, Atul; Gottlieb, Alice B; Boehncke, Wolf-Henning; Dong, Bin; ... Hsia, Elizabeth C |
2018 |
unige:159650 |
EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future |
Alunno, Alessia; Rivellese, Felice; Lauper, Kim; Aletaha, Daniel; ... Sepriano, Alexandre |
2021 |
unige:127794 |
EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology |
Dejaco, Christian; Putrik, Polina; Unger, Julia; Aletaha, Daniel; ... Buttgereit, Frank |
2018 |
unige:157622 |
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis |
Mankia, Kulveer; Siddle, Heidi J; Kerschbaumer, Andreas; Alpizar Rodriguez, Deshire; ... Emery, Paul |
2021 |
unige:157635 |
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors |
Kostine, Marie; Finckh, Axel; Bingham, Clifton O; Visser, Karen; ... Schaeverbeke, Thierry |
2021 |
unige:154813 |
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update |
Gossec, Laure; Baraliakos, Xenofon; Kerschbaumer, Andreas; de Wit, Maarten; ... Smolen, Josef S |
2020 |
unige:151663 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update |
Smolen, Josef S; Landewé, Robert B M; Bijlsma, Johannes W J; Burmester, Gerd R; ... van der Heijde, Désirée |
2020 |
unige:157651 |
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools |
Burmester, Gerd-Rüdiger; Álvaro-Gracia, José María; Betteridge, Neil; Calvo Alén, Jaime; ... van de Laar, Mart |
2020 |
unige:127780 |
GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual Meeting |
Furer, Victoria; Manasson, Julia; Boehncke, Wolf-Henning; Ritchlin, Christopher T |
2018 |
unige:154812 |
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial |
Deodhar, Atul; Helliwell, Philip S; Boehncke, Wolf-Henning; Kollmeier, Alexa P; ... Ritchlin, Christopher T |
2020 |